Searched for
COMPETITIVE GENERIC THERAPY
Cipla in no hurry to launch semaglutide as Yurpeak gains tractionCipla is focusing on its tirzepatide brand Yurpeak in India's obesity market. Yurpeak has become the second largest GLP-1 product since its...23 Jul, 2026, 10.24 PM IST- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...22 Jul, 2026, 03.00 PM IST
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...16 Jun, 2026, 06.27 PM IST
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...10 Jun, 2026, 06.16 PM IST
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...09 Jun, 2026, 05.30 AM IST
- A blockbuster unleashed: What happens when a big fat business explodes?India is set to experience a dramatic shift as Ozempic and Wegovy's active ingredient, semaglutide, becomes widely available. Over 40 India...21 Mar, 2026, 10.51 AM IST
- Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhalerGlenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step i...04 Mar, 2026, 03.47 PM IST
- Dr Reddy's says Wegovy copycat to be priced competitively, with 50-60% discounts feasibleIndian drugmaker Dr Reddy's Laboratories is set to launch a generic version of the popular weight-loss drug Wegovy. The company aims to off...17 Feb, 2026, 10.36 PM IST
- Obesity drugs shed niche tag, set to gain more weight in India pharmaIndia's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster therapies. The ...26 Dec, 2025, 03.13 PM IST
- Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivityIndoco Remedies Ltd was granted approval from the USFDA to sell its generic Lofexidine tablets, used for opioid withdrawal. This approval i...21 Aug, 2024, 02.44 PM IST
- Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drugZydus Lifesciences has gained the US Food and Drug Administration's (FDA) approval to produce and market its Indomethacin suppositories. Th...03 Aug, 2023, 03.32 PM IST
- Dr Reddy's launches generic epilepsy drug in US market"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North Ame...02 Feb, 2021, 03.02 PM IST
- Dr Reddy's Labs launches generic injection indicated for abortion in USThe company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said i...06 Dec, 2019, 01.47 PM IST
- Desi pharma companies see big business in competitive genericsThe opportunity for domestic companies could cumulatively fetch up to a billion dollars in sales.13 Mar, 2019, 12.31 PM IST
- Pharma sector growth may remain strong: ICRAThe recent acquisition by companies such as Lupin and Cipla are likely to further support scaling-up of business, it said.04 Oct, 2015, 01.01 PM IST
- Indian drug makers need to shift focus to complex therapies than mere launches: JefferiesIndian pharma companies, who have built their revenues by selling generic drugs to developed markets, might have to shift their business st...06 Jul, 2012, 05.45 PM IST
- Pharma cos focus on specialist therapiesPharma cos's emphasis is shifting to more focused therapies for specific cancers, immunological conditions and complex diseases.07 Mar, 2009, 10.41 AM IST
Load More
